Development and validation of a combined hypoxia and immune prognostic classifier for head and neck cancer JM Brooks, AN Menezes, M Ibrahim, L Archer, N Lal, CJ Bagnall, ... Clinical Cancer Research 25 (17), 5315-5328, 2019 | 90 | 2019 |
Collagen induces a more proliferative, migratory and chemoresistant phenotype in head and neck cancer via DDR1 SL Lai, ML Tan, RJ Hollows, M Robinson, M Ibrahim, S Margielewska, ... Cancers 11 (11), 1766, 2019 | 46 | 2019 |
Aberrant expression of the S1P regulating enzymes, SPHK1 and SGPL1, contributes to a migratory phenotype in OSCC mediated through S1PR2 SN Patmanathan, SP Johnson, SL Lai, S Panja Bernam, V Lopes, W Wei, ... Scientific reports 6 (1), 25650, 2016 | 44 | 2016 |
Oncogenic S1P signalling in EBV‐associated nasopharyngeal carcinoma activates AKT and promotes cell migration through S1P receptor 3 HM Lee, KW Lo, W Wei, SW Tsao, GTY Chung, MH Ibrahim, CW Dawson, ... The Journal of pathology 242 (1), 62-72, 2017 | 41 | 2017 |
Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program M Granai, L Mundo, AU Akarca, MC Siciliano, H Rizvi, V Mancini, ... Infectious agents and cancer 15, 1-8, 2020 | 34 | 2020 |
S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells K Vrzalikova, M Ibrahim, M Vockerodt, T Perry, S Margielewska, L Lupino, ... Leukemia 32 (1), 214-223, 2018 | 33 | 2018 |
Sphingosine-1-phosphate signalling drives an angiogenic transcriptional programme in diffuse large B cell lymphoma L Lupino, T Perry, S Margielewska, R Hollows, M Ibrahim, M Care, ... Leukemia 33 (12), 2884-2897, 2019 | 29 | 2019 |
Co-expression of the Epstein-Barr virus-encoded latent membrane proteins and the pathogenesis of classic Hodgkin lymphoma K Vrzalikova, M Ibrahim, E Nagy, M Vockerodt, T Perry, W Wei, ... Cancers 10 (9), 285, 2018 | 21 | 2018 |
Down‐regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV‐associated nasopharyngeal carcinoma LF Yap, S Velapasamy, HM Lee, S Thavaraj, P Rajadurai, W Wei, ... The Journal of pathology 235 (3), 456-465, 2015 | 21 | 2015 |
Tetraspanin 6 is a regulator of carcinogenesis in colorectal cancer R Andrijes, RK Hejmadi, M Pugh, S Rajesh, V Novitskaya, M Ibrahim, ... Proceedings of the National Academy of Sciences 118 (39), e2011411118, 2021 | 18 | 2021 |
Primitive neuroectodermal tumor (PNET) of the lung in an adult woman M Gachechiladze, J Škarda, M Ibrahim, T Tichý, P Flodr, P Latálová, ... World Journal of Surgical Oncology 12, 1-5, 2014 | 15 | 2014 |
Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC‐subtype diffuse large B‐cell lymphoma M Vockerodt, K Vrzalikova, M Ibrahim, E Nagy, S Margielewska, ... The Journal of pathology 248 (2), 142-154, 2019 | 10 | 2019 |
Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial … M Nohtani, K Vrzalikova, M Ibrahim, JE Powell, É Fennell, S Morgan, ... Cancers 14 (17), 4297, 2022 | 5 | 2022 |
Role of EBV in classical hodgkin lymphoma P Murray, M Ibrahim Precision Molecular Pathology of Hodgkin Lymphoma, 91-109, 2018 | 3 | 2018 |
LC3A positive “stone like structures” are differentially associated with survival outcomes and CD68 macrophage infiltration in patients with lung adenocarcinoma and squamous … M Gachechiladze, I Uberall, D Skanderova, J Matchavariani, M Ibrahim, ... Lung Cancer 156, 129-135, 2021 | 1 | 2021 |
Correction to: Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program M Granai, L Mundo, AU Akarca, MC Siciliano, H Rizvi, V Mancini, ... Infectious Agents and Cancer 15, 2020 | 1 | 2020 |
Hypoxia-inducible Factor-1α and mTOR as a Potential Therapeutic Target in Endometriosis: An Immunohistochemical Study DM Badary, HA Abou-Taleb, M Ibrahim Applied Immunohistochemistry & Molecular Morphology 31 (9), 629-634, 2023 | | 2023 |
Impact of Tumour Epstein-Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL) M Nohtani, K Vrzalikova, M Ibrahim, JE Powell, É Fennell, S Morgan, ... | | 2022 |
Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program G Massimo, L Mundo, AU Akarca, MC Siciliano, R Hasan, V Mancini, ... University of Nairobi, 2020 | | 2020 |
Correction: S1PR1 drives a feedforward signalling loop to regulate BATF3 and the transcriptional programme of Hodgkin lymphoma cells K Vrzalikova, M Ibrahim, M Vockerodt, T Perry, S Margielewska, L Lupino, ... Leukemia 33 (8), 2126, 2019 | | 2019 |